The amyloid precursor protein (APP) is proteolytically processed by -and ␥-secretases to release amyloid , the main component in senile plaques found in the brains of patients with Alzheimer disease. Alternatively, APP can be cleaved within the amyloid  domain by ␣-secretase releasing the non-amyloidogenic product sAPP␣, which has been shown to have neuroprotective properties. Several G protein-coupled receptors are known to activate ␣-secretase-dependent processing of APP; however, the role of G protein-coupled nucleotide receptors in APP processing has not been investigated. Here it is demonstrated that activation of the G proteincoupled P2Y 2 receptor (P2Y 2 R) subtype expressed in human 1321N1 astrocytoma cells enhanced the release of sAPP␣ in a time-and dose-dependent manner. P2Y 2 Rmediated sAPP␣ release was dependent on extracellular calcium but was not affected by 1,2-bis(2-aminophenoxy)ethane-N,N,N,-trimethylammonium salt, an intracellular calcium chelator, indicating that P2Y 2 R-stimulated intracellular calcium mobilization was not involved. Inhibition of protein kinase C (PKC) with GF109203 or by PKC down-regulation with phorbol ester pre-treatment had no effect on UTP-stimulated sAPP␣ release, indicating a PKC-independent mechanism. U0126, an inhibitor of the mitogen-activated protein kinase pathway, partially inhibited sAPP␣ release by UTP, whereas inhibitors of Src-dependent epidermal growth factor receptor transactivation by P2Y 2 Rs had no effect. The metalloprotease inhibitors phenanthroline and TAPI-2 and the furin inhibitor decanoyl-ArgVal-Lys-Arg-chloromethylketone also diminished UTPinduced sAPP␣ release. Furthermore, small interfering RNA silencing of an endogenous adamalysin, ADAM10 or ADAM17/TACE, partially suppressed P2Y 2 R-activated sAPP␣ release, whereas treatment of cells with both ADAM10 and ADAM17/TACE small interfering RNAs completely abolished UTP-activated sAPP␣ release. These results may contribute to an understanding of the non-amyloidogenic processing of APP.P2 nucleotide receptors modulate a wide range of physiological responses following their activation by extracellular nucleotides (1, 2). The G protein-coupled P2Y 2 receptor (P2Y 2 R) 1 subtype is fully activated by equivalent concentrations of ATP or UTP (3-5) and is up-regulated in salivary gland models of stress and disease (6 -8) as well as in blood vessels after balloon angioplasty and in collared carotid arteries, where it induces intimal hyperplasia and inflammation by increasing smooth muscle cell proliferation and leukocyte infiltration (9, 10). Moreover, nucleotides are released from damaged cells of all tissues and from excited neurons, aggregating platelets, and contracting smooth muscle under physiological conditions (2, 11).The diversity of cellular responses mediated by P2Y 2 Rs is due in part to unique structural features that enable these receptors to stimulate a variety of signal transduction pathways. In addition to the classical stimulation of G␣ q -dependent phospholipase C (12, 13), the P2Y 2 R c...